According to Race Oncology's latest financial reports the company's current EPS (TTM) is -HK$0.32. In 2023 the company made an earnings per share (EPS) of -HK$0.32 an increase over its 2022 EPS that were of -HK$0.39.
Year | EPS | Change |
---|---|---|
2023 | -HK$0.32 | -18.46% |
2022 | -HK$0.39 | 37.74% |
2021 | -HK$0.28 | 47% |
2020 | -HK$0.19 | -23.41% |
2019 | -HK$0.25 | -53.58% |
2018 | -HK$0.54 | 14.62% |
2017 | -HK$0.47 | 190.27% |
2016 | -HK$0.16 | |
2015 | N/A |